EDSA
Edesa Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$4.87
+2.31%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.33x
- Price / sales
- —
- Price / cash flow
- -5.24x
Enterprise value
- Enterprise value
- $45.0M
- EV / sales
- —
- EV / EBITDA
- -3.15x
- EV / EBIT
- -3.08x
- Market cap
- $47.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026